SCS/HCS/HB 1366 & 1878 - This act allows a pharmacist filling a prescription order for a brand name biological product to select a less expensive interchangeable biological product if the substitute has been approved by the FDA to be an interchangeable biological product, the prescriber has communicated that a interchangeable biological product may be substituted, and the pharmacist informs the patient. Within five days of dispensing a biological product, the pharmacist shall communicate the name and manufacturer of the product to the prescriber, unless there is no FDA approved interchangeable biological product or a refill prescription is not changed from the product dispensed on the prior filling. The Board of Pharmacy shall maintain a link on its website to a current list of all biological products determined by the FDA to be interchangeable with a specific biological product. This act is identical to SB 875 (2016). JESSI BAKER
|